Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis

Cell Biology and Toxicology

Volumn 18, Issue 1, 2002, Pages 51-61

  Corbel, M ^a   Belleguic, C ^a,b   Boichot, E ^a   Lagente, V ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Fibrosis; Inflammation; Lung; Matrix metalloproteinase; TIMP

Indexed keywords

BATIMASTAT; BLEOMYCIN; GELATINASE; GELATINASE A; GELATINASE B; HYDROXYPROLINE; PROTEINASE INHIBITOR;

AIRWAY DYNAMICS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FATALITY; INFLAMMATION; LUNG FIBROSIS; LUNG INTERSTITIUM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RESPIRATORY TRACT DISEASE; REVIEW; SYMPTOMATOLOGY;

EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PNEUMONIA; PULMONARY FIBROSIS;

ANIMALIA;

EID: 0036211999     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014471213371     Document Type: Review

References (52)

1. Reduced gelatinase activity by the selective phosphodiesterase type 4 inhibitor, RP 73401, in sensitized mice
2. Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients
3. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B
4. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin
5. Proteolytic remodeling of extracellular matrix
6. MMP- 2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease
7. Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide
8. Increase activity of matrix metalloproteinase and collagen deposition after chronic administration of antigen in sensitized BP2 mouse
9. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor, batimastat
10. Modulation of airway remodeling-associated mediators by the antifibrotic compound pirfenidone and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury
11. Repeated endotoxin exposure induces intersitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity
12. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane
13. 72-Kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: A clinicopathologic, immunohistochemical, and serological study
14. Matrix metalloproteinase inhibitors: Present achievements and future prospects
15. Localisation of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitiallung diseases
16. Conagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis
17. Effects of the phosphodiesterase 4 inhibitor, RP 73401, and interleukin-10 on acute pulmonary inflammation and metalloproteinase activity (MMP-9) in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide
18. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis
19. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase
20. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
21. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model
22. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters
23. Macrophage production of transforming growth factor f3 and fibroblast collagen synthesis in chronic pulmonary inflammation
24. Increased production and immunohistochemical localization of transforming growth factor-f3 in idiopathic pulmonary fibrosis
25. Imbalance between matrix metalloproteinase (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in the bronchoalveolar lavage of patients with long-lasting ARDS
26. Overexpression of alveolar macrophage gelatinase B (MMP- 9) in patients with idiopathic pulmonary fibrosis: Effects of steroid and immunosuppressive treatment
27. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids
28. Identification and characterization of human MT5-MMP (MMP-24), a new membrane-bound activator of pro-gelatinase a over-expressed in brain tumors
29. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors
30. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis
31. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
32. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics
33. The matrix metalloproteinases and their inhibitors
34. Matrix metalloproteases and lung disease
35. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis
36. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation
37. Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lung
38. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: Pathogenetic implications
39. Matrix metalloproteinases in lung biology
40. Leukolysin/MMP-25/MT6-MMP: A novel matrix metalloproteinase specifically expressed in the leukocyte lineage
41. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome
42. Subepithelial fibrosis in the bronchi of asthmatics
43. Potential role of proteases in pulmonary fibrosis
44. TIMP- 1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment
45. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis
46. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: Its role in lung disease
47. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9 and fibrosis in lung
48. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members
49. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis
50. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice
51. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models
52. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis